Topical tacrolimus in alopecia areata.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15627095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Eleven patients with alopecia areata affecting 10% to 75% of the scalp, average duration 6 years, had no terminal hair growth in response to tacrolimus ointment 0.1% applied twice daily for 24 weeks. Treatment failure may reflect insufficient depth of penetration of the ointment formulation and less than optimal patient selection.
Medical subject headings
- Alopecia Areata
- Immunosuppressive Agents
- Tacrolimus